ASRS
NTLA icon

Arizona State Retirement System’s Intellia Therapeutics NTLA Stock Holding History

Arizona State Retirement System’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$598K Buy
35,356
+5,131
+17% +$71.8K ﹤0.01% 1448
2026
Q1 		$387K Buy
30,225
+1,585
+6% +$20.2K ﹤0.01% 1597
2025
Q4 		$257K Sell
28,640
-453
-2% -$6.24K ﹤0.01% 1819
2025
Q3 		$502K Buy
29,093
+431
+2% +$5.31K ﹤0.01% 1515
2025
Q2 		$269K Buy
28,662
+935
+3% +$7.68K ﹤0.01% 1780
2025
Q1 		$197K Sell
27,727
-279
-1% -$2.82K ﹤0.01% 1896
2024
Q4 		$327K Buy
28,006
+1,615
+6% +$25.2K ﹤0.01% 1704
2024
Q3 		$542K Buy
26,391
+743
+3% +$17.1K ﹤0.01% 1437
2024
Q2 		$574K Buy
25,648
+2,267
+10% +$54K ﹤0.01% 1347
2024
Q1 		$643K Sell
23,381
-119
-0.5% -$3.31K ﹤0.01% 1295
2023
Q4 		$717K Buy
23,500
+914
+4% +$26.3K 0.01% 1253
2023
Q3 		$714K Buy
22,586
+336
+2% +$13K 0.01% 1182
2023
Q2 		$907K Buy
22,250
+1,731
+8% +$70.2K 0.01% 1076
2023
Q1 		$765K Buy
20,519
+1,216
+6% +$47.7K 0.01% 1155
2022
Q4 		$673K Buy
19,303
+751
+4% +$35.7K 0.01% 1204
2022
Q3 		$1.04M Buy
18,552
+401
+2% +$24.9K 0.01% 916
2022
Q2 		$939K Buy
18,151
+46
+0.3% +$2.34K 0.01% 995
2022
Q1 		$1.32M Buy
18,105
+304
+2% +$25.8K 0.01% 911
2021
Q4 		$2.1M Buy
17,801
+1,093
+7% +$137K 0.02% 714
2021
Q3 		$2.24M Buy
16,708
+139
+0.8% +$21K 0.02% 671
2021
Q2 		$2.68M Buy
16,569
+2,810
+20% +$219K 0.02% 612
2021
Q1 		$1.1M Buy
13,759
+131
+1% +$8.79K 0.01% 1046
2020
Q4 		$741K Sell
13,628
-96
-0.7% -$3.49K 0.01% 1233
2020
Q3 		$273K Buy
+13,724
New +$286K ﹤0.01% 1641

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $177M AUM 9.82% 1-Year Est. Return

Arizona State Retirement System's NTLA Position: Q2 2026 in Review

Arizona State Retirement System increased its Intellia Therapeutics (NTLA) stake by 17% in Q2 2026, buying an estimated $71.8K and bringing the position to 35,356 shares worth $598K. The position accounts for ﹤0.01% of the portfolio, ranked #1448.

Arizona State Retirement System first reported a position in NTLA in Q3 2020 and has held it in 24 quarters since. The position peaked at $2.68M in Q2 2021. 328 funds tracked by Wall St. Rank hold NTLA as of Q2 2026.

  • Arizona State Retirement System held 35,356 shares of Intellia Therapeutics worth $598K as of Q2 2026.
  • Arizona State Retirement System bought 5,131 Intellia Therapeutics shares in Q2 2026, an estimated $71.8K.
  • Intellia Therapeutics made up ﹤0.01% of Arizona State Retirement System's portfolio in Q2 2026, its #1448 holding.
  • Arizona State Retirement System first reported a position in Intellia Therapeutics in Q3 2020 and has held it in 24 quarters since.
  • Arizona State Retirement System's Intellia Therapeutics position peaked at $2.68M in Q2 2021.
  • 328 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q2 2026.

Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.